1,572
Views
31
CrossRef citations to date
0
Altmetric
Clinical Research Articles

Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections

, DPM, MPH, , DPM, MS, , MD, , DPM, MS, , DPM & , DPM
Article: 23575 | Received 13 Dec 2013, Accepted 10 Mar 2014, Published online: 10 Apr 2014

References

  • Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis. 2007; 44: 562–5.
  • Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, etal. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004; 39: 885–910.
  • Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, etal. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. 2006; 12: 186–9.
  • Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, etal. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012; 54: e132–73.
  • Lipsky BA, Peters EJ, Berendt AR, Senneville E, Bakker K, Embil JM, etal. Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev. 2012; 28(Suppl 1): 234–5.
  • Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?. Infect Control Hosp Epidemiol. 1999; 20: 473–7.
  • Reddy SL, Grayson AD, Smith G, Warwick R, Chalmers JA. Methicillin resistant Staphylococcus aureus infections following cardiac surgery: incidence, impact and identifying adverse outcome traits. Eur J Cardiothorac Surg. 2007; 32: 113–17.
  • Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med. 2003; 20: 159–61.
  • Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JLK, Jarlier V, Grimaldi A. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med. 2004; 21: 710–15.
  • Richard JL, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes Metab. 2008; 34: 363–9.
  • Aragon-Sanchez J, Lazaro-Martinez JL, Quintana-Marrero Y, etal. Are diabetic foot ulcers complicated by MRSA osteomyelitis associated with worse prognosis? Outcomes of a surgical series. Diabet Med. 2009; 26: 552–5.
  • Demling RH, Waterhouse B. The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus. J Burns Wounds. 2007; 7: e8. [PubMed Abstract] [PubMed CentralFull Text].
  • Ding Q, Li DQ, Wang PH, Chu YJ, Meng SY, Sun Q. [Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients]. Zhonghua yi xue za zhi. 2012; 92: 228–31. [PubMed Abstract].
  • Stanaway S, Johnson D, Moulik P, Gill G. Methicillin-resistant Staphylococcus aureus (MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage. Diabetes Res Clin Pract. 2007; 75: 47–50.
  • Yates C, May K, Hale T, Allard B, Rowlings N, Freeman A, etal. Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Diabetes Care. 2009; 32: 1907–9.
  • Taha AB. Relationship and susceptibility profile of Staphylococcus aureus infection diabetic foot ulcers with Staphylococcus aureus nasal carriage. Foot (Edinb). 2013; 23: 11–16.